Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSt James's Place Regulatory News (STJ)

Share Price Information for St James's Place (STJ)

Share Price is delayed by 15 minutes
Get Live Data
1,193.50    1.00 (0.08%)
Bid:
1,190.00
Ask:
1,191.00
Spread: 1.00 (0.084%)
Market Cap: £6.07b
STJ Live PriceLast checked at - London Stock Exchange

Intraday St James's Place Share Chart

Director/PDMR Shareholding

25 Oct 2017 09:23

St. James’s Place plc (“SJP”)

SJP was notified on 24 October 2017 of the following changes in SJP shares held by the Executive Directors named below.

SJP Performance Share Plan 2005 (“PSP”) and linked Company Share Option Plan 2010 (“CSOP”)

CSOP

On 26 March 2014 the following Executive Directors (“the Directors”) were awarded a CSOP-linked award, whereby they were granted a nil-cost unapproved option pursuant to the PSP and a linked HMRC-approved CSOP share option:

Andrew Croft, Chief Financial Officer

Ian Gascoigne, Managing Director

David Lamb, Managing Director

The Directors exercised the linked CSOP award on 24 October 2017 with an exercise price of £8.515 per share and, as a result, their linked PSP awards automatically lapsed in respect of the number of shares equal in value to the gain realised upon exercise of the linked CSOP award.

Column 1 sets out the number of SJP shares acquired as a result of the exercise of the linked CSOP award on 24 October 2017, and column 2 sets out the number of SJP shares sold on 24 October 2017 at £11.81 pence per share by the Directors. Column 3 sets out the number of shares that have lapsed under the linked PSP award as a result of these exercises, and Column 4 sets out the number of PSP award shares retained under the linked PSP award.

CSOP 1 2 3 4
Name of Director Number of SJP shares acquired on exercise of CSOP option Number of SJP shares sold Number of SJP shares that have lapsed under the linked PSP award Number of SJP shares retained under the linked PSP award
Andrew Croft 3,054 3,054 853 72,312
Ian Gascoigne 3,054 2,632 853 72,312
David Lamb 3,054 3,054 853 72,312

PSP

On 26 March 2014 the Directors were awarded nil cost unapproved PSP awards. On 24 October 2017 the Directors exercised those awards, as set out in the table below.

Column 1 sets out the number of SJP shares exercised, column 2 sets out the number of SJP shares sold on 24 October 2017 at a price of £11.72 pence per share by the Directors in order to settle income tax and National Insurance liabilities, and column 3 sets out the number of additional SJP shares sold by the Directors at £11.72. Column 4 sets out the number of SJP shares retained.

PSP 1 2 3 4
Name of Director Number of SJP shares exercised Number of SJP shares sold to meet tax liability Number of Additional SJP Shares Sold Number of SJP shares retained
Andrew Croft 72,312 33,987 19,210 19,115
Ian Gascoigne 72,312 33,987 19,210 19,115
David Lamb 72,312 33,987 38,325 0

Following the above transactions, Ian Gascoigne gifted at nil cost 19,537 SJP shares to Gail Gascoigne, a Person Closely Associated with him, on 24 October 2017.

This notification is made in accordance with EU Market Abuse Regulation.

LEI: 213800M993ICXOMBCP87

Classification: 3.1 Additional regulated information required to be disclosed under the laws of a Member State

Deputy Company Secretary, Tel: +44 (0)1285 717237

25 October 2017

View source version on businesswire.com: http://www.businesswire.com/news/home/20171025005470/en/

Copyright Business Wire 2017

Date   Source Headline
21st Jun 20193:07 pmRNSNotification of Major Holdings
10th Jun 20194:29 pmRNSCorrection: Holding(s) in Company
10th Jun 20191:18 pmRNSHolding(s) in Company
10th Jun 201911:29 amRNSHolding(s) in Company
10th Jun 201911:12 amRNSHolding(s) in Company
10th Jun 201911:00 amRNSHolding(s) in Company
10th Jun 201910:36 amRNSHolding(s) in Company
10th Jun 201910:10 amRNSHolding(s) in Company
10th Jun 20197:43 amRNSHolding(s) in Company
10th Jun 20197:00 amRNSNotification of Major Holdings
7th Jun 20196:00 pmRNSHolding(s) in Company
7th Jun 20195:29 pmRNSHolding(s) in Company
7th Jun 20195:12 pmRNSHolding(s) in Company
7th Jun 20195:07 pmRNSHolding(s) in Company
7th Jun 20194:58 pmRNSHolding(s) in Company
7th Jun 20194:58 pmRNSHolding(s) in Company
7th Jun 20194:56 pmRNSHolding(s) in Company
7th Jun 20194:25 pmRNSHolding(s) in Company
5th Jun 20194:00 pmRNSChanges to management of St. James's Place funds
3rd Jun 20192:14 pmRNSTotal Voting Rights
15th May 201911:48 amRNSDirector/PDMR Shareholding
14th May 20192:29 pmRNSResult of AGM
2nd May 201912:29 pmRNSDirector/PDMR Shareholding
1st May 20194:25 pmRNSTotal Voting Rights
30th Apr 20197:00 amRNSQ1 New Business Inflows and Funds under Management
1st Apr 20192:20 pmRNSTotal Voting Rights
27th Mar 20196:04 pmRNSDirector/PDMR Shareholding
7th Mar 20197:00 amRNSAdditional Listing
7th Mar 20197:00 amRNSAdditional Listing
1st Mar 20193:12 pmRNSTotal Voting Rights
27th Feb 20197:00 amRNSFinal Results
1st Feb 201911:48 amRNSBlock listing Interim Review
1st Feb 201911:48 amRNSTotal Voting Rights
24th Jan 20197:00 amRNSQ4 New Business Inflows and Funds under Management
8th Jan 20194:46 pmRNSHolding(s) in Company
2nd Jan 20194:02 pmRNSTotal Voting Rights
31st Dec 201812:50 pmRNSHolding(s) in Company
7th Dec 201812:47 pmRNSHolding(s) in Company
3rd Dec 201812:36 pmRNSTotal Voting Rights
29th Nov 20185:00 pmRNSHolding(s) in Company
28th Nov 20184:06 pmRNSHolding(s) in Company
23rd Nov 20184:04 pmRNSDirector Declaration
16th Nov 20184:33 pmRNSHolding(s) in Company
16th Nov 20183:27 pmRNSHolding(s) in Company
16th Nov 20183:24 pmRNSHolding(s) in Company
24th Oct 20182:09 pmRNSHolding(s) in Company
23rd Oct 201812:12 pmRNSHolding(s) in Company
23rd Oct 20187:00 amRNSQ3 New Business Inflows and Funds under Management
12th Oct 201811:01 amRNSHolding(s) in Company
8th Oct 20181:01 pmRNSUpdate to Board succession plans

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.